{"id":"NCT02024529","sponsor":"Ampio Pharmaceuticals. Inc.","briefTitle":"A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee","officialTitle":"A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of a Single Intra-articular Injection of Ampion in Adults With Pain Due to Osteoarthritis (OA) of the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01","primaryCompletion":"2014-05","completion":"2014-07","firstPosted":"2013-12-31","resultsPosted":"2022-08-09","lastUpdate":"2022-08-09"},"enrollment":538,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis of the Knee"],"interventions":[{"type":"BIOLOGICAL","name":"4 mL injection of Ampion","otherNames":[]},{"type":"DRUG","name":"4 mL Injection of Placebo","otherNames":["Saline"]}],"arms":[{"label":"AMPION™ 4 mL dose","type":"EXPERIMENTAL"},{"label":"Placebo 4 mL dose","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the efficacy of an Intra-Articular Injection of Ampion™ in Adults with pain due to osteoarthritis of the knee.","primaryOutcome":{"measure":"Change in WOMAC A Pain","timeFrame":"Scored at Baseline and 12 weeks","effectByArm":[{"arm":"Ampion 4 mL Injection","deltaMin":-0.81,"sd":null},{"arm":"Placebo 4 mL Injection","deltaMin":-0.81,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.97"}]},"eligibility":{"minAge":"35 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29156068"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":269},"commonTop":["Arthralgia","Upper Respiratory Tract Infection","Pain in Extremity","Sinusitis","Fall"]}}